Bangladesh Medical College Observational Study: Ivermectin Works as PrEP for Health Care Workers Against COVID-19
Dr. Tarek Alam, who has participated in interviews with TrialSite News in the past, along with a sizeable research team from the Bangladesh Medical College and the Shomman Foundation
had their COVID-19 research involving what Dr. Alam terms “the people’s medicine” published in the peer review European Journal of Medical & Health Sciences (EJMED) recently.
The results were notable, perhaps even compelling.
Out of 60 subjects in the control group, 44 (73.3%) were positive for COVID-19 while only 4 out of 58 (6.9%) of the experimental group ultimately succumbed to a SARS-CoV-2 infection, the virus behind COVID-19.
Albeit not a randomized controlled study, these findings are but one of a growing many associated with case series, observational and a few randomized controlled studies
pointing to material evidence that Ivermectin does serve to inhibit and perhaps even block COVID-19.
Of course, more research is required: TrialSite has evangelized for the National Institutes of Health (NIH) to invest in a study.、